Dr Reddy’s Laboratories Ltd
The live share price of Dr Reddy's Laboratories Ltd (DRREDDY) as on 29 Sep 10:22am is ₹5,587 from NSE/BSE.
DRREDDY NSE
₹5,587 ▲2.91% (157.9)
As on Sep 29, 2023 03:52 PM IST
Key Metrics
PE Ratio
19.13
PB Ratio
3.88
Dividend Yield
0.74%
Sector PB
4.66
Sector PE
39.72
Sector Div Yld
0.78%
Dividend Yield
Dividend per share for the most recent financial year divided by the close price
About
Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines.
The following charts display the financial performance of the Dr Reddy's Laboratories Ltd (DRREDDY) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.
Furthermore, under the Peers section, you can find stocks that are similar to Dr Reddy's Laboratories Ltd (DRREDDY), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.
✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.
A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.
All smallcases are created and managed by SEBI-registered investment experts.
To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.
Financials
Income Statement
(INR) | Y/Y Change | |
Revenue | 25,762 Cr | +16.57% |
Operating Expense | 2,477 Cr | -9.21% |
Net Income | 4,507 Cr | +106.52% |
Net Profit Margin | 17.5% | +77.13% |
Earning Per Share | 270 | +106.38% |
EBITDA | 7,441 Cr | +72.16% |
Balance sheet
(INR) | Y/Y Change | |
Cash & short-term Inv | 6,179 Cr | +39.29% |
Total Assets | 32,209 Cr | +8.28% |
Total Liabilities | 8,923 Cr | -15.29% |
Total Equity | 23,286 Cr | +21.2% |
Shares Outstanding | 16.65 Cr | +0.04% |
Price to Book | 3.31 | -10.71% |
Return on Assets | 14.55% | +87.74% |
Return on Capital | 26.59 Cr | +61.84% |
Cash Flows
(INR) | Y/Y Change | |
Net Income | 4,507 Cr | +106.52% |
Cash from Operations | 5,887 Cr | +109.46% |
Cash from Investing | -4,108 Cr | +60.16% |
Cash from Financing | -2,686 Cr | +1009.04% |
Net Change in Cash | -907 Cr | -28453.12% |
Free Cash Flow | 4,000 Cr | +341.65% |
Peers
SUNPHARMA
Sun Pharmaceutical Industries Ltd
PE Ratio
32.21
1Y Return
▲24.49%
CIPLA
Cipla Ltd
PE Ratio
30.21
1Y Return
▲6.3%
MANKIND
Mankind Pharma Ltd
PE Ratio
47.88
1Y Return
▲24.06%
TORNTPHARM
Torrent Pharmaceuticals Ltd
PE Ratio
49.7
1Y Return
▲24.8%
Latest News

Dr Reddy’s Laboratories incorporates wholly-owned subsidiary in Jamaica; stock rises 1%
19 hours ago on Moneycontrol
Change since news ▼-2.91%
Dr Reddy’s stock has given a return of 18.88 percent over the last six months. The benchmark Nifty50 index has given a return of 14.30 percent over the same duration.

Taking Stock: Nifty falls 105 points from day’s high to end flat as banks underperform
1 month ago on Moneycontrol
Change since news ▲2.39%
Top gainers on the Nifty included Tata Steel, Maruti Suzuki, M&M, Eicher Motors and Infosys, while the top losers were Power Grid Corporation, SBI, BPCL, Dr Reddy’s Laboratories and Hero MotoCorp

Trade setup for Thursday: Top 15 things to know before the opening bell
1 month ago on Moneycontrol
Change since news ▲6.15%
Based on the OI percentage, 54 stocks were on the short-covering list. These included State Bank of India, Axis Bank, Dr Reddy’s Laboratories, Maruti Suzuki, and Hindustan Copper.
FAQs on Dr Reddy's Laboratories Ltd
How to buy Dr Reddy's Laboratories Ltd stocks?
You can easily buy the stocks/shares of Dr Reddy's Laboratories Ltd (DRREDDY) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.
What is the Share Price of Dr Reddy's Laboratories Ltd?
The stock price of Dr Reddy's Laboratories Ltd as on 29 Sep 2023 is ₹5,587
What is the 52-week High and Low of Dr Reddy's Laboratories Ltd?
The 52-week high and low of Dr Reddy's Laboratories Ltd (DRREDDY) is ₹5,989.7 and ₹4,175.1.
What is the PE and PB ratio of Dr Reddy's Laboratories Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Dr Reddy's Laboratories Ltd are 19.13 and 3.88 respectively.
What are the peers or stocks similar to Dr Reddy's Laboratories Ltd?
The peers or stocks similar to Dr Reddy's Laboratories Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Mankind Pharma Ltd, Torrent Pharmaceuticals Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.
Which sector does Dr Reddy's Laboratories Ltd belong to?
Dr Reddy's Laboratories Ltd (DRREDDY) belongs to the Pharmaceuticals sector.
What is the Market Cap of Dr Reddy's Laboratories Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dr Reddy's Laboratories Ltd (DRREDDY) is ₹90,361 Cr as of 29 Sep 2023
Can't decide whether or not to buy Dr Reddy's Laboratories Ltd stocks? ⭐️
Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.